Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial

OBJECTIVES: Lupus nephritis (LN) is a frequent complication of systemic lupus erythematosus (SLE). Severe (proliferative) forms of LN are treated with induction immunosuppressive therapy (IST), followed by maintenance IST, to target remission and avoid relapses. The optimal duration of maintenance I...

Descripción completa

Detalles Bibliográficos
Autores principales: Jourde-Chiche, Noemie, Costedoat-Chalumeau, Nathalie, Baumstarck, Karine, Loundou, Anderson, Bouillet, Laurence, Burtey, Stéphane, Caudwell, Valérie, Chiche, Laurent, Couzi, Lionel, Daniel, Laurent, Deligny, Christophe, Dussol, Bertrand, Faguer, Stanislas, Gobert, Pierre, Gondran, Guillaume, Huart, Antoine, Hummel, Aurélie, Kalbacher, Emilie, Karras, Adexandre, Lambert, Marc, Le Guern, Véronique, Lebourg, Ludivine, Loubière, Sandrine, Maillard-Lefebvre, Hélène, Maurier, François, Pha, Micheline, Queyrel, Viviane, Remy, Philippe, Sarrot-Reynauld, Françoise, Verhelst, David, Hachulla, Eric, Amoura, Zahir, Daugas, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Systemic Lupus Erythematosus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484365/
https://www.ncbi.nlm.nih.gov/pubmed/35725295
http://dx.doi.org/10.1136/annrheumdis-2022-222435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484365/
https://www.ncbi.nlm.nih.gov/pubmed/35725295
http://dx.doi.org/10.1136/annrheumdis-2022-222435

Ejemplares similares